Latest updates for Arwr
Fresh curated links around ARWR are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Arrowhead Pharmaceuticals: The Fast-Follower Math Behind A $215 Million Voucher
- Arrowhead Pharmaceuticals, Inc. (ARWR) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript
- Arrowhead
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Arrowhead Pharmaceuticals, Inc. (ARWR) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript
Arrowhead
Arrowhead Anonymous (not verified) Fri, 10/23/2026 - 13:17 field_thread_url https://cafepharma.com/boards/threads/arrowhead.708698/ boar...
Arrowhead Pharmaceuticals Director Sells 11,600 Shares for $1 Million
Perry's liquidity event comes as the Arrowhead stock price surged.
ARMOUR Residential REIT, Inc. (ARR) Q3 2026 Earnings Call Transcript
Day 11 of $QQQ short term up-trend, its Weekly 10.4 Stochastic= 86, a sign of a strong up-trend, see GMI table; ARW had...
IndicatorsGMI: 3/6GMI-2: 6/9T2108: 21%I think this market is strengthening into 3rd quarter earnings. Many down markets have bottomed in October. Remember to “come back at Hallowee...
AARD Deadline: AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit
NEW YORK, Oct. 2, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Aardvark Therapeutics, Inc. (NASDAQ: AARD): (i) common stock pu...
AmRest Holdings SE (ARHOF) Q2 2026 Earnings Call Transcript
ARS Pharmaceuticals Deadline: SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit
NEW YORK, Oct. 2, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) between March...
AAR (AIR) Q1 2027 Earnings Call Transcript
MRO Holdings acquisition positions AAR for $4.3B revenue scale and 19-20% margins.
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit
NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) between Marc...
AWM 2026 Direction
AWM 2026 Direction Anonymous (not verified) Wed, 09/23/2026 - 21:57 field_thread_url https://cafepharma.com/boards/threads/awm-2026-direction.712673/...
Arrow Exploration Corp. (AXL:CA) Shareholder/Analyst Call Prepared Remarks Transcript
Ironwood Pharmaceuticals: The Stock Is A Call On The Second Apraglutide Trial - Buy
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.